SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Разъяснения и дополнения к SPIRIT 2013: руководство по протоколам клинических испытаний
2013-01-09
SCID: 54.1/n3aamexy
Discuss with AI
SPIRIT 2013 Statementclinical trial protocolsinterventional trialsprotocol reportingprotocol transparency
Figures from the paper
Abstract (AI)
High quality protocols facilitate proper conduct, reporting, and external review of clinical trials. However, the completeness of trial protocols is often inadequate. To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Standard Protocol Items: Recommendations for Interventional Trials). The SPIRIT Statement provides guidance in the form of a checklist of recommended items to include in a clinical trial protocol. This SPIRIT 2013 Explanation and Elaboration paper provides important information to promote full understanding of the checklist recommendations. For each checklist item, we provide a rationale and detailed description; a model example from an actual protocol; and relevant references supporting its importance. We strongly recommend that this explanatory paper be used in conjunction with the SPIRIT Statement. A website of resources is also available (www.spirit-statement.org). The SPIRIT 2013 Explanation and Elaboration paper, together with the Statement, should help with the drafting of trial protocols. Complete documentation of key trial elements can facilitate transparency and protocol review for the benefit of all stakeholders.
Key Findings
1
Complete documentation of key trial elements can improve trial transparency, conduct, reporting, external review, and stakeholder benefit.
2
The Explanation and Elaboration paper clarifies every SPIRIT checklist item through its rationale, detailed description, real-world protocol example, and supporting references.
3
The SPIRIT 2013 Statement provides a checklist of recommended items for clinical trial protocols to improve their content and quality.
4
The guidance was developed because clinical trial protocols are often incomplete, limiting their quality and usefulness.
5
Using the explanatory paper alongside the SPIRIT Statement is strongly recommended to promote complete understanding and application of the recommendations.
Research Object
Clinical trial protocols
Research Subject
completeness, transparency, quality, and proper documentation of key trial elements in protocols
Publication Details
Publication Date
2013-01-09
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration2009
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants2017
Guidance for Developers of Health Research Reporting Guidelines2010